February 2012 – “A more rigorous evaluation of potential vaccine-related adverse health impacts in pediatric populations than what has been provided to date is urgently needed.” is the conclusion of the latest in a series of evidence-based studies on aluminum vaccine adjuvants. The study is published in Lupus, the only fully peer reviewed international journal devoted exclusively to the autoimmune disease, lupus, and related research topics. A PRWeb™ news release, quotes the study by Lucija Tomljenovic PhD and Chris Shaw PhD of the University of British Columbia which “confirms that immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune system function.”
The study summarizes: “Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In some developed countries, by the time children are 4 to 6 years old, they will have received a total of 126 antigenic compounds along with high amounts of aluminum (Al) adjuvants through routine vaccinations. According to the US Food and Drug Administration, safety assessments for vaccines have often not included appropriate toxicity studies because vaccines have not been viewed as inherently toxic. Taken together, these observations raise plausible concerns about the overall safety of current childhood vaccination programs.”
The authors point out that, “When assessing adjuvant toxicity in children, several key points ought to be considered: 1) During prenatal and early postnatal development the brain is extremely vulnerable to neurotoxic insults; 2) Aluminum is a neurotoxin and a strong immune stimulant. Hence, aluminum has all the necessary biochemical properties to induce neuro-immune diseases. Autism is one such disease. Namely, autism is characterized by dysfunctional immunity and abnormalities in brain function; 3) In adult humans aluminum vaccine adjuvants have been linked to a variety of serious autoimmune and inflammatory conditions, yet children are regularly exposed to much higher amounts of aluminum from vaccines than adults; 4) It is often incorrectly assumed that peripheral immune challenges (analogous to vaccinations) do not affect brain function. However, it is now clearly established that there is a cross-talk between the nervous and the immune system. It is also demonstrated that this cross-talk plays a crucial role in both immunoregulation as well as brain function. In turn, perturbations of the neuro-immune regulatory system have been demonstrated in many autoimmune diseases and are thought to be driven by a hyperactive immune response; 5) The same components of the neuro-immune regulatory system that have key roles in both brain development and immune function are heavily affected by aluminum adjuvants; In summary, research evidence shows that increasing concerns about current vaccination practices may indeed be warranted. Because children may be most at risk of vaccine-induced complications, a rigorous evaluation of the vaccine-related adverse health impacts in the pediatric population is urgently needed.”
However, Dr. Paul Offit apparently rejects this rigorously-arrived-at, evidence-based conclusion and, apparently does so for no other reason than it doesn’t suit his pro-vaccine ideology. ‘Responses to UBC vaccine paper a problem for free scientific inquiry and expression’, a Vancouver Courier article, quotes Offit as saying that the paper “should never have been published”. And, as if to discredit this new evidence re vaccine harm along with any such evidence previously published, Offit once again trotted out the withdrawal of the 1998 Lancet study authored by Dr. Andrew Wakefield, claiming that it had caused avoidable deaths of children whose parents refused MMR vaccinations. In fact, Wakefield has filed suit for defamation against the journalist and medical journal whose publications aid Offit and others of his persuasion in continuing to make such claims.
Another study by Tomljenovic and Shaw published last year in Journal of Inorganic Chemistry concludes that “the correlation between Al [aluminum] and ASD [Autism Spectrum Disorders] may be causal. Because children represent a fraction of the population most at risk for complications following exposure to Al, a more rigorous evaluation of Al adjuvant safety seems warranted.” And backing both studies, a third study by the same authors and published earlier last year in Current Medical Chemistry concludes: “The continued use of aluminum adjuvants in various vaccines for children as well as the general public may be of significant concern. In particular, aluminum presented in this form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences.”
A majority of the many infant/early childhood vaccines and the school children’s vaccines plus tetanus vaccine – all funded by Canadian taxpayers – contain aluminum. The longer medical authorities/personnel disregard the mounting evidence of the risks of these vaccines, the more likely Canadians will reject them. A much worse consequence would be extensive injury such that many present day and future children will be unable to be normally functioning contributors to society if and by the time they reach adulthood.
